Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)

被引：0

作者：

Ahmed Eraky ^{[1
]}

Reuben Ben-David ^{[1
]}

Gabriele Bignante ^{[2
]}

Zhenjie Wu ^{[3
]}

Linhui Wang ^{[3
]}

Randall Lee ^{[4
]}

Andres F. Correa ^{[4
]}

Daniel D. Eun ^{[4
]}

Alessandro Antonelli ^{[5
]}

Alessandro Veccia ^{[5
]}

Francesco Ditonno ^{[5
]}

Firas Abdollah ^{[6
]}

Alex Stephens ^{[6
]}

Shane Tinsley ^{[6
]}

Daniel Sidhom ^{[7
]}

Chandru P. Sundaram ^{[7
]}

Sol C. Moon ^{[8
]}

Soroush Rais-Bahrami ^{[8
]}

Mark L. Gonzalgo ^{[9
]}

Omri Falik Nativ ^{[9
]}

Francesco Porpiglia ^{[10
]}

Daniele Amparore ^{[11
]}

Enrico Checcucci ^{[10
]}

Antonio Tufano ^{[10
]}

Sisto Perdonà ^{[11
]}

Stephan Brönimann ^{[12
]}

Nirmish Singla ^{[12
]}

Ottavio De Cobelli ^{[13
]}

Matteo Ferro ^{[13
]}

Giuseppe Simone ^{[14
]}

Gabriele Tuderti ^{[14
]}

Margaret F. Meagher ^{[15
]}

Ithaar H. Derweesh ^{[15
]}

Takashi Yoshida ^{[16
]}

Hidefumi Kinoshita ^{[16
]}

Raj Bhanvadia ^{[17
]}

Ali H. Zahalka ^{[17
]}

Vitaly Margulis ^{[18
]}

Farshad S. Moghaddam ^{[18
]}

Hooman Djaladat ^{[18
]}

Riccardo Autorino ^{[19
]}

Reza Mehrazin ^{[19
]}

机构：

[1] Icahn School of Medicine at Mount Sinai Hospital,Department of Urology

[2] One Gustave L. Levy Place,Department of Urology

[3] Rush University,Department of Urology

[4] Changhai Hospital,Department of Urology

[5] Naval Medical University,Department of Urology

[6] Fox Chase-Temple Urologic Institute,Department of Urology

[7] University of Verona,Desai Sethi Urology Institute

[8] Vattikuti Urology Institute,Division of Urology

[9] Henry Ford Hospital,Department of Surgery

[10] Indiana University,School of Medicine

[11] University of Alabama at Birmingham Heersink School of Medicine,Division of Urology

[12] University of Miami Miller School of Medicine,Department of Urology

[13] University of Turin,Department of Urology

[14] San Luigi Gonzaga Hospital,Department of Urology and Andrology

[15] Candiolo Cancer Institute,Department of Urology

[16] FPO-IRCCS,Norris Comprehensive Cancer Center, Institute of Urology

[17] Istituto Nazionale Tumori Di Napoli,undefined

[18] IRCCS “Fondazione G. Pascale”,undefined

[19] Brady Urological Institute,undefined

[20] Johns Hopkins Medicine,undefined

[21] European Institute of Oncology (IEO)-IRCCS,undefined

[22] IRCCS “Regina Elena” National Cancer Institute,undefined

[23] UC San Diego School of Medicine,undefined

[24] Kansai Medical University,undefined

[25] University of Texas Southwestern Medical Center,undefined

[26] University of Southern California,undefined

来源：

World Journal of Urology | / 43卷 / 1期

关键词：

UTUC; Neoadjuvant; Adjuvant; Recurrence; Survival;

D O I：

10.1007/s00345-025-05605-5

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Real-world management of high-risk upper tract urothelial carcinoma: Level of adherence to EAU guidelines - analysis of the ROBUUST registry
Tuderti, G.
Proietti, F.
Wu, Z.
Franco, A.
Abdollah, F.
Finati, M.
Ferro, M.
Tozzi, M.
Porpiglia, F.
Checcucci, E.
Margulis, V
Singla, N.
Derweesh, I. H.
Correa, A.
Gonzalgo, M. L.
Mehrazin, R.
Sundaram, C. P.
Tufano, A.
Perdona, S.
Djaladat, H.
Ditonno, F.
Antonelli, A.
Autorino, R.
Simone, G.
EUROPEAN UROLOGY, 2024, 85 : S798 - S799
[32] Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
Luo, Yong
Feng, Bingfu
Wei, Dechao
Han, Yili
Li, Mingchuan
Zhao, Jiahui
Lin, Yunhua
Hou, Zhu
Jiang, Yongguang
SCIENTIFIC REPORTS, 2020, 10 (01)
[33] Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity
Yong Luo
Bingfu Feng
Dechao Wei
Yili Han
Mingchuan Li
Jiahui Zhao
Yunhua Lin
Zhu Hou
Yongguang Jiang
Scientific Reports, 10
[34] Risk Factors and Predictive Value of Local Recurrence in Chinese Upper Tract Urothelial Carcinoma Patients: Implication for Postoperative Adjuvant Radiation Therapy
Li, X.
Gao, X.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E92 - E93
[35] Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis
Hsu, Heng-Yuan
Chao, Yin-Kai
Hsieh, Chia-Hsun
Wen, Yu-Wen
Chang, Hsien-Kun
Tseng, Chen-Kan
Liu, Yun-Hen
ANNALS OF THORACIC SURGERY, 2016, 102 (05): : 1687 - 1693
[36] 60 Versus 66 Gy for Adjuvant Radiation Therapy in High-Risk p16+Oropharyngeal Carcinoma
Chin, R.
Spencer, C. R.
Hwang, M. Y.
Patel, P.
Gay, H.
Haughey, B. H.
Nussenbaum, B.
Adkins, D.
Lewis, J. S.
Thorstad, W. L.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 471 - 472
[37] Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study
Ikeda, Masaomi
Matsumoto, Kazumasa
Hirayama, Takahiro
Koguchi, Dai
Murakami, Yasukiyo
Matsuda, Daisuke
Okuno, Norihiko
Utsunomiya, Takuji
Taoka, Yoshinori
Irie, Akira
Iwamura, Masatsugu
CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E669 - E675
[38] Effectiveness and safety of pembrolizumab, nivolumab, and atezolizumab as adjuvant therapy for high-risk muscle-invasive urothelial carcinoma: an indirect comparison
Chen, Wei
Yoshida, Soichiro
Miura, Noriyoshi
Fukuda, Shohei
Fukushima, Hiroshi
Waseda, Yuma
Tanaka, Hajime
Fujii, Yasuhisa
FRONTIERS IN ONCOLOGY, 2025, 14
[39] Total neoadjuvant treatment versus standard therapy (neoadjuvant radiochemotherapy and adjuvant chemotherapy) of rectal cancer with high-risk factors for local or systemic recurrence
Tuta, M.
Boc, N.
Peternel, M.
Anderluh, F.
Oblak, I.
Secerov-Ermenc, A.
Peressutti, A. Jeromen
Brecelj, E.
Velenik, V.
ANNALS OF ONCOLOGY, 2020, 31 : S147 - S147
[40] Clinical effectiveness of tislelizumab combined with gemcitabine/cisplatin (GC) versus GC as adjuvant therapy in high-risk muscle-invasive urothelial carcinoma (MIUC): A real-world study
Tan, X.
Wu, Z.
Wang, Y.
Yao, K.
ANNALS OF ONCOLOGY, 2023, 34 : S1560 - S1560

← 1 2 3 4 5 →